Cost-Effectiveness of Fixed-Dose Combinations Therapies for Chronic Obstructive Pulmonary Disease Treatment.

Margarita CapelMareque MaríaCarlos José ÁlvarezLeandro LindnerItziar Oyagüez

Published in: Clinical drug investigation (2018)

ACL/FF 400/12 µg was a cost-saving therapy in patients with moderate-to-severe COPD in Spain, and provided equivalent effects compared to TIO/OLO 5/5 µg.

Keyphrases

chronic obstructive pulmonary disease
lung function
high intensity
quantum dots
stem cells
replacement therapy